Us Bancorp »

Perspective Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-09-30 $88k 6.6k 13.35
2024-06-30 $27k 2.7k 9.97

More positions owned by Us Bancorp

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Us Bancorp

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management

View all funds holding Perspective Therapeutics